[go: up one dir, main page]

ES2005746A6 - Un procedimiento para la preparacion de un haluro de piridinio. - Google Patents

Un procedimiento para la preparacion de un haluro de piridinio.

Info

Publication number
ES2005746A6
ES2005746A6 ES8703768A ES8703768A ES2005746A6 ES 2005746 A6 ES2005746 A6 ES 2005746A6 ES 8703768 A ES8703768 A ES 8703768A ES 8703768 A ES8703768 A ES 8703768A ES 2005746 A6 ES2005746 A6 ES 2005746A6
Authority
ES
Spain
Prior art keywords
aryl
preparation
formula
piperidine esters
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8703768A
Other languages
English (en)
Inventor
Gary Thomas Borrett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES2005746A6 publication Critical patent/ES2005746A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

EL COMPUESTO (II) EN QUE AR ES ARILO O ARILO SUSTITUIDO, R3 Y R4, IGUALES O DIFERENTES, SON ALQUILO Y HAL ES HALOGENO, SE OBTIENE POR CUATERNIZACION DE (III) EN QUE AR Y R4 SON LOS DEFINIDOS ANTES CON UN HALUURO DE ALQUILO HAL-R3, EN QUE HAL REPRESENTA HALOGENO Y R3 ES ALQUILO O ARILO.ESTOS COMPUESTOS TIENEN UTILIDAD COMO INTERMEDIOS EN LA PREPARACION DE ARIL-PIPERIDIN ESTERES QUE SE EMPLEAN COMO ANTIDEPRESIVOS.
ES8703768A 1985-08-10 1987-12-30 Un procedimiento para la preparacion de un haluro de piridinio. Expired ES2005746A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858520154A GB8520154D0 (en) 1985-08-10 1985-08-10 Chemical process

Publications (1)

Publication Number Publication Date
ES2005746A6 true ES2005746A6 (es) 1989-03-16

Family

ID=10583642

Family Applications (2)

Application Number Title Priority Date Filing Date
ES8600961A Expired ES2000604A6 (es) 1985-08-10 1986-08-08 Un procedimiento para preparar aril-piperidin esteres
ES8703768A Expired ES2005746A6 (es) 1985-08-10 1987-12-30 Un procedimiento para la preparacion de un haluro de piridinio.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES8600961A Expired ES2000604A6 (es) 1985-08-10 1986-08-08 Un procedimiento para preparar aril-piperidin esteres

Country Status (10)

Country Link
US (1) US4861893A (es)
EP (1) EP0219934B1 (es)
JP (4) JPH0699389B2 (es)
CA (1) CA1290340C (es)
DE (1) DE3682253D1 (es)
ES (2) ES2000604A6 (es)
GB (1) GB8520154D0 (es)
GR (1) GR862099B (es)
MX (1) MX173379B (es)
PT (1) PT83180B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
ES2132187T3 (es) * 1992-06-04 1999-08-16 Micro Flo Co Cloruro de mepiquat.
US5446057A (en) * 1993-09-24 1995-08-29 Warner-Lambert Company Substituted tetrahydropyridine and piperidine carboxylic acids as muscarinic antagonists
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
ES2121684B1 (es) * 1996-03-15 1999-08-16 Vita Invest Sa Procedimiento para la obtencion de (+)-cis / (+)-trans-4-(4-fluorofenil)-1-metilpiperidina-3-carboxilato de etilo.
JP3446468B2 (ja) 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
EP1384720A1 (en) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Process for drying paroxetine hydrochloride
CA2214288C (en) * 1996-09-18 2006-07-18 Lonza Ag Process for the preparation of 1-acyl-4-arylpiperidines
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
ATE433959T1 (de) * 1997-04-07 2009-07-15 Univ Georgetown Analoge von kokain
WO1998053824A1 (en) 1997-05-29 1998-12-03 Smithkline Beecham Corporation Novel process
ES2155995T3 (es) * 1997-06-10 2001-06-01 Synthon Bv Compuestos de 4-fenilpiperidina.
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9924855D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel processes
GB9924882D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel process
AU1037701A (en) * 1999-10-20 2001-04-30 Smithkline Beecham Plc Process for the preparation of 4-(fluorophenyl)piperidine esters
US6833458B2 (en) 2000-06-05 2004-12-21 Development Center For Biotechnology Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates
WO2002032870A1 (en) * 2000-10-20 2002-04-25 Smithkline Beecham P.L.C. Process of the preparation of 3-substituted-4-aryl piperidine compounds
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE336414C (de) * 1919-06-21 1921-05-03 Chem Fab Verfahren zur Darstellung von Hexahydroderivaten der N-Methylpyridin-3-carbonsaeureester (N-Methylnicotinsaeureester)
DE574137C (de) * 1925-08-12 1933-04-10 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von Piperidin und seinen Abkoemmlingen
CH369132A (de) * 1958-08-12 1963-05-15 Cilag Chemie Aktiengesellschaf Verfahren zur Herstellung von Nipecotinsäureamiden
US3922278A (en) * 1972-06-12 1975-11-25 Sterling Drug Inc 4-(3-Nitrophenyl)-3,5-pyridinedicarboxylic acid
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel

Also Published As

Publication number Publication date
JPH0794442B2 (ja) 1995-10-11
ES2000604A6 (es) 1988-03-01
GB8520154D0 (en) 1985-09-18
GR862099B (en) 1986-12-30
JPH0699389B2 (ja) 1994-12-07
PT83180B (pt) 1989-03-30
EP0219934A1 (en) 1987-04-29
DE3682253D1 (de) 1991-12-05
JPH07149728A (ja) 1995-06-13
EP0219934B1 (en) 1991-10-30
PT83180A (en) 1986-09-01
JPH07138231A (ja) 1995-05-30
JPS6239568A (ja) 1987-02-20
JPH07138229A (ja) 1995-05-30
US4861893A (en) 1989-08-29
MX173379B (es) 1994-02-23
JPH08810B2 (ja) 1996-01-10
CA1290340C (en) 1991-10-08
JPH0794443B2 (ja) 1995-10-11

Similar Documents

Publication Publication Date Title
ES2000604A6 (es) Un procedimiento para preparar aril-piperidin esteres
ES2000603A6 (es) Un procedimiento para preparar aril-piperidino carbinoles
CA1238910A (en) CARBOXYALKENOIC ACIDS
NO823836L (no) Fremgangsmaate ved fremstilling av antifibrinolytisk aktive forbindelser.
ES2001341A6 (es) Un procedimiento de producir un derivado de acido guanidinometilbenzoico.
PL268034A1 (en) The method of manufacture of new 7-phenylglycil-1-carbo-destiacephalosphorines
ATE217869T1 (de) Verfahren zur herstellung von fluoralkenylthio heterozyclische derivate
DK381488A (da) Fremgangsmaade til fremstilling af cephemforbindelser og cephalosporinderivater opnaaet ved fremgangsmaaden
ES8206462A1 (es) Un metodo para preparar derivados de 2-oxoazetidina.
FI873443A7 (fi) Norfloxacinmellanprodukt.
ES2068663T3 (es) Procedimiento para la preparacion de compuestos de piridina sustituidos con halogenosulfonilo.
ES8304972A1 (es) Procedimiento de preparar derivados de acido carboxilico quetienen actividad antibacteriana.
EP0206765A3 (en) Process for preparation of rooperol, hypoxoside and derivatives thereof
DE3363575D1 (en) Furyloxazolylacetic acid derivatives, process for preparing same and pharmaceutical compositions containing same
ES8200092A1 (es) Procedimiento para la sintesis de esteres de la n-(4'hidro- xifenil) acetamida con acidos 5-benzoil-1-metilpirrol-2-ace-tico
ES8704447A1 (es) Un procedimiento para preparar el homero s de un 3-eter de 2-hidroxi -profil-amina.
CA2182241A1 (en) Methods for the manufacture of nefazodone
JPS57156440A (en) Novel derivatives of 4-methyl-3-formylpentanoic acid, manufacture and use for manufacturing cyclic derivatives
FI863897L (fi) Kemiskt foerfarande.
FR2446818A1 (fr) Tetrahydro-2h-benzo(c)pyrroles utiles comme intermediaires
IE791324L (en) Process for preparing cis-bicylooctylamines.
ES8304546A1 (es) Un procedimiento de preparacion de zomepirac y sus analogos.
ES8505657A1 (es) Procedimiento para la preparacion de quinolinonas-4
ATE64381T1 (de) Verfahren zur herstellung von betalactamderivaten.
ATE90101T1 (de) Verfahren zur herstellung von makrolid-derivaten.